Apollo Endosurgery, Inc. (APEN) News

Apollo Endosurgery, Inc. (APEN): $10.00

0.08 (+0.81%)

POWR Rating

Component Grades








Filter APEN News Items

APEN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

APEN News Highlights

  • APEN's 30 day story count now stands at 2.
  • Over the past 25 days, the trend for APEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest APEN News From Around the Web

Below are the latest news stories about APOLLO ENDOSURGERY INC that investors may wish to consider to help them evaluate APEN as an investment opportunity.

Apollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

Apollo Endosurgery ( NASDAQ:APEN ) Full Year 2022 Results Key Financial Results Revenue: US$76.9m (up 22% from FY...

Yahoo | April 1, 2023

Does This Valuation Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Imply Investors Are Overpaying?

Key Insights Apollo Endosurgery's estimated fair value is US$7.40 based on 2 Stage Free Cash Flow to Equity Apollo...

Yahoo | March 7, 2023

Analysts Are Downgrading These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks. Microsoft Corporation (NASDAQ:MSFT) is in the news after the company posted fiscal Q2 results. The company’s revenue outlook for the March […]

Yahoo | January 26, 2023

Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet earlier this year(1), was selected as 2022 Top Story in Gastroenterology.(2) Additionally, the American Society for Metabolic and Bariatric Surgery (ASMBS) formally added four Apollo systems to its list of FDA Approved Bariatric Devices

Yahoo | December 13, 2022

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

Yahoo | November 30, 2022

Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday Woes

Bed Bath & Beyond (BBBY) stock is bouncing back on Tuesday after the retail company's shares took a dive Monday on poor Black Friday sales.

William White on InvestorPlace | November 29, 2022

Why Is Otonomy (OTIC) Stock Up 97% Today?

Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company.

William White on InvestorPlace | November 29, 2022

Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal

Apollo Endosurgery is about to be acquired by Boston Scientific.

Samuel O'Brient on InvestorPlace | November 29, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | November 29, 2022

Investors Liked These 2 Stock Buyouts Tuesday

Investors settled in for a largely quiet trading session on Tuesday. With a speech expected from Federal Reserve chair Jerome Powell on Wednesday, most market participants were content to wait and see what the central banker will say about the future path of monetary policy.

Yahoo | November 29, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!